Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Matinas Biopharma Hl (MTNB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart
Realtime quote and/or trade prices are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 110,611
  • Shares Outstanding, K 92,950
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,600 K
  • 36-Month Beta 0.51
  • Price/Sales 1,229.01
  • Price/Cash Flow N/A
  • Price/Book 15.52

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.02 +18.63%
on 10/27/17
1.26 -3.97%
on 11/15/17
-0.02 (-1.63%)
since 10/20/17
3-Month
1.02 +18.63%
on 10/27/17
1.47 -17.69%
on 10/12/17
-0.11 (-8.33%)
since 08/21/17
52-Week
1.01 +19.80%
on 08/02/17
3.99 -69.67%
on 03/02/17
-0.33 (-21.43%)
since 11/21/16

Most Recent Stories

More News
Matinas BioPharma Reports 2017 Third Quarter Financial Results and Provides Corporate Update

Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, today announced its financial results...

MTNB : 1.20 (+0.84%)
Matinas BioPharma to Present at the Dawson James Securities 3rd Annual Small Cap Growth Conference

Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, announced today that Jerome D. Jabbour,...

MTNB : 1.20 (+0.84%)
Matinas BioPharma to Present at the Cantor Fitzgerald Global Healthcare Conference

Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, announced today that Jerome D. Jabbour,...

MTNB : 1.20 (+0.84%)
Daily Technical Summary Reports on Biotech Stocks -- Actinium Pharma, BioPharmX, Matinas BioPharma, and 22nd Century

If you want a Stock Review on ATNM, BPMX, MTNB, or XXII then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. Today, DailyStockTracker.com revisits the Biotechnology...

BPMX : 0.13 (-31.58%)
XXII : 2.40 (+1.69%)
ATNM : 0.66 (-1.49%)
MTNB : 1.20 (+0.84%)
Matinas BioPharma to Present at the Canaccord Genuity 37th Annual Growth Conference

- Presentation with live audio webcast on Thursday, August 10th at 11:00 AM EDT -

MTNB : 1.20 (+0.84%)
Stock Performance Review on Biotech Industry -- BioPharmX, AmpliPhi Biosciences, Actinium Pharma, and Matinas BioPharma

If you want a Stock Review on BPMX, APHB, ATNM, or MTNB then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. On Monday, the NASDAQ Composite ended...

BPMX : 0.13 (-31.58%)
APHB : 0.91 (-1.09%)
ATNM : 0.66 (-1.49%)
MTNB : 1.20 (+0.84%)
Matinas BioPharma Reports Topline Data from Phase 2 Clinical Study of Orally-Administered MAT2203 for the Treatment of Vulvovaginal Candidiasis

Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, today reported topline data from its...

MTNB : 1.20 (+0.84%)
Matinas BioPharma Presents Positive Preclinical Efficacy Data of MAT2203 in Mouse Model of Cryptococcal Meningoencephalitis

Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, today announced the presentation of...

MTNB : 1.20 (+0.84%)
Matinas BioPharma to Present at the 2017 Jefferies Global Healthcare Conference

Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, announced today that Jerome D. Jabbour,...

MTNB : 1.20 (+0.84%)
Matinas BioPharma Appoints Dominick DiPaolo as Senior Vice President of Quality and Regulatory Compliance

Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, announced today that it has appointed...

MTNB : 1.20 (+0.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Matinas BioPharma Holdings, Inc. is a development stage biopharmaceutical company. It focuses on identifying and developing pharmaceutical products for the treatment of abnormalities in blood lipids and the treatment of cardiovascular and metabolic diseases. The Company primarily focuses on developing...

See More

Key Turning Points

2nd Resistance Point 1.22
1st Resistance Point 1.20
Last Price 1.20
1st Support Level 1.17
2nd Support Level 1.16

See More

52-Week High 3.99
Fibonacci 61.8% 2.85
Fibonacci 50% 2.50
Fibonacci 38.2% 2.15
Last Price 1.20
52-Week Low 1.01

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart